Type Private Area served Worldwide Founded 1994 | Industry Medical Diagnostics Number of employees 1,001 to 5,000 (2014) Parent organization The Carlyle Group | |
 | ||
Key people Martin D. Madaus (Chairman) and (CEO)
Charles Wagner (CFO)
Robert Yates (COO)
Kristie K. Bouryal (CBO) and (CCO)
Michael Schlesinger (CLO) Website orthoclinicaldiagnostics.com Headquarters Raritan, New Jersey, United States Subsidiaries Ortho-Clinical Diagnostics K.K. | ||
Ortho Clinical Diagnostics is an in vitro diagnostics company that makes products and diagnostic equipment for blood testing. Ortho serves two primary industries in the medical field: clinical laboratories, by producing platforms and assays that test for a variety of diseases, conditions, and substances; and immunohematology, by providing the means to ensure blood transfusion recipients receive appropriate and compatible blood. Johnson and Johnson acquired Eastman Kodak's Clinical Diagnostics Division in 1994 (to form Johnson & Johnson Clinical Diagnostics), which was then merged with Ortho Diagnostic Systems in 1997. Ortho's global corporate offices are in Raritan, New Jersey, while their global research and development center is in Rochester, New York.
Contents
In 2014, The Carlyle Group purchased the company from Johnson & Johnson for $4.15 billion. Ortho Clinical Diagnostics now operates as an independent company.
Ortho Clinical Diagnostics (Ortho) unveiled its newly expanded executive leadership team following the acquisition of the company by The Carlyle Group from Johnson & Johnson. In his first act as Ortho's Chairman and CEO, Dr. Martin D. Madaus announced key appointments in finance, operations, legal and commercial to advance strategic sectors of the In Vitro Diagnostics (IVD) business.
Johnson johnson ortho clinical diagnostics
History
1939: Ortho Products, Inc., is formed in Linden, New Jersey, as a division of Johnson & Johnson.
1944: Dr. Philip Levine, a pioneer in the field of hematology, joins Ortho Products to continue his research into the mechanics of the Rh system in human blood.
1997: Ortho Diagnostics Systems and Johnson & Johnson Clinical Diagnostics merge and begin operating as Ortho Clinical Diagnostics.
2001: Ortho becomes the first diagnostic company to receive US FDA approval for automated random access hepatitis tests.
2006: Ortho launches the first FDA-licensed test to screen blood donations for exposure to Chagas disease.
2014: The Carlyle Group acquires Ortho Clinical Diagnostics for $4.15 billion.
2015: Ortho receives FDA clearance for its ORTHO VISION Analyzer, which automates the full range of immunohematology testing and helps improve the safety of blood transfusions by reducing laboratories' reliance on manual methods.